Financial Ratios Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse Other stock markets 04:00:03 2026-01-21 pm EST			5-day change	1st Jan Change
180.06 ^USD	+4.36%		+1.41%	+27.30%

Jan. 21	When America Starts to Feel Like a Risky Asset
Jan. 21	Oppenheimer Adjusts Price Target on Albemarle to $207 From $109, Maintains Outperform Rating	MT

9.gBYFmjUpFRegAu3GotHVNhxpncTz9LEC0Q6UTwEfcSQ.8XQoy0Jee3_DVtSDwZCbaSg56_DGvvdI4DbEHER5BRTZJUPfBRp0RMlkoA

Published financial data: ALBEMARLE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.13B	3.33B	7.32B	9.62B	5.38B
Total Revenues	3.13B	3.33B	7.32B	9.62B	5.38B
Cost of Goods Sold, Total	2.13B	2.32B	4.24B	8.42B	5.29B
Gross Profit	997M	1.01B	3.08B	1.2B	84.24M
Selling General & Admin Expenses, Total	427M	347M	439M	644M	595M
R&D Expenses	59.21M	54.03M	71.98M	85.72M	86.72M
Other Operating Expenses, Total	486M	401M	511M	730M	682M
Operating Income	510M	607M	2.57B	467M	-598M
Interest Expense, Total	-73.12M	-32.52M	-104M	-116M	-166M
Interest And Investment Income	-	-	-	19.3M	36.3M
Net Interest Expenses	-73.12M	-32.52M	-104M	-96.77M	-129M
Income (Loss) On Equity Invest.	128M	95.77M	772M	1.85B	715M
Currency Exchange Gains (Loss)	-28.8M	100K	-21.8M	39.9M	67.5M
Other Non Operating Income (Expenses)	6.63M	-24.74M	44.51M	80.27M	122M
EBT, Excl. Unusual Items	543M	646M	3.26B	2.34B	178M
Restructuring Charges	-19.9M	-3.03M	-4.3M	-11.8M	-1.18B
Merger & Related Restructuring Charges	-17.26M	-12.67M	-16.26M	-26.77M	-6.22M
Impairment of Goodwill	-	-	-	-6.76M	-
Gain (Loss) On Sale Of Investments	7.2M	-	4.3M	31.96M	-72.86M
Gain (Loss) On Sale Of Assets	3.6M	296M	-8.4M	-	40.9M
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	7.3M	-
Legal Settlements	1.2M	-668M	100K	-234M	-
Other Unusual Items	-16.5M	-28.96M	-27.62M	-4.1M	-7.2M
EBT, Incl. Unusual Items	501M	229M	3.21B	2.1B	-1.05B
Income Tax Expense	54.42M	29.45M	391M	430M	87.08M
Earnings From Continuing Operations	447M	200M	2.82B	1.67B	-1.14B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	447M	200M	2.82B	1.67B	-1.14B
Minority Interest	-70.85M	-76.27M	-125M	-97.07M	-43.97M
Net Income - (IS)	376M	124M	2.69B	1.57B	-1.18B
Preferred Dividend and Other Adjustments	-	-	-	-	137M
Net Income to Common Incl Extra Items	376M	124M	2.69B	1.57B	-1.32B
Net Income to Common Excl. Extra Items	376M	124M	2.69B	1.57B	-1.32B
Per Share Items
Net EPS - Basic	3.53	1.07	22.97	13.41	-11.2
Basic EPS - Continuing Operations	3.53	1.07	22.97	13.41	-11.2
Basic Weighted Average Shares Outstanding	106M	116M	117M	117M	118M
Net EPS - Diluted	3.52	1.06	22.84	13.36	-11.2
Diluted EPS - Continuing Operations	3.52	1.06	22.84	13.36	-11.2
Diluted Weighted Average Shares Outstanding	107M	117M	118M	118M	118M
Normalized Basic EPS	2.52	2.83	16.32	11.66	0.57
Normalized Diluted EPS	2.51	2.81	16.22	11.62	0.57
Dividend Per Share	1.54	1.56	1.58	1.6	1.61
Payout Ratio	43.06	143.81	6.86	11.9	-26.39
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	742M	861M	2.87B	897M	-9.11M
EBITA	535M	633M	2.59B	495M	-575M
EBIT	510M	607M	2.57B	467M	-598M
EBITDAR	797M	923M	2.93B	991M	88.61M
Effective Tax Rate - (Ratio)	10.86	12.84	12.18	20.48	-8.31
Current Domestic Taxes	-333K	12.42M	38.2M	-57.64M	212M
Current Foreign Taxes	56.73M	55.53M	259M	387M	105M
Total Current Taxes	56.4M	67.95M	297M	329M	317M
Deferred Domestic Taxes	1.67M	-43.96M	80.54M	-12.7M	-171M
Deferred Foreign Taxes	-3.65M	5.46M	12.8M	114M	-59.46M
Total Deferred Taxes	-1.98M	-38.5M	93.34M	101M	-230M
Normalized Net Income	268M	327M	1.91B	1.37B	67.09M
Interest Capitalized	30.4M	50M	31.1M	72.7M	49M
Interest on Long-Term Debt	104M	82.48M	135M	189M	215M
Non-Cash Pension Expense	41.41M	-77.37M	-48.09M	-2.95M	-18.96M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	59.21M	54.03M	71.98M	85.72M	86.72M
Net Rental Expense, Total	54.26M	61.42M	65.86M	93.62M	97.72M
Imputed Operating Lease Interest Expense	13.03M	12.95M	24.07M	36.9M	42.16M
Imputed Operating Lease Depreciation	41.23M	48.48M	41.79M	56.72M	55.56M
Stock-Based Comp., Other (Total)	19.3M	18.8M	31.4M	39M	33.1M
Total Stock-Based Compensation	19.3M	18.8M	31.4M	39M	33.1M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	747M	439M	1.5B	890M	1.19B
Total Cash And Short Term Investments	747M	439M	1.5B	890M	1.19B
Accounts Receivable, Total	531M	557M	1.19B	1.21B	742M
Other Receivables	107M	143M	258M	622M	323M
Total Receivables	638M	700M	1.45B	1.84B	1.07B
Inventory	750M	813M	2.08B	2.16B	1.5B
Prepaid Expenses	57.53M	49.93M	156M	324M	77.19M
Other Current Assets, Total	13.86M	5.8M	6.72M	6.6M	4.75M
Total Current Assets	2.21B	2.01B	5.19B	5.22B	3.84B
Gross Property Plant And Equipment	7.56B	8.23B	9.48B	12.37B	12.64B
Accumulated Depreciation	-2.07B	-2.17B	-2.39B	-2.74B	-3.19B
Net Property Plant And Equipment	5.49B	6.06B	7.09B	9.63B	9.45B
Long-term Investments	656M	898M	1.15B	1.37B	1.12B
Goodwill	1.67B	1.6B	1.62B	1.63B	1.58B
Other Intangibles, Total	349M	309M	288M	262M	231M
Deferred Tax Assets Long-Term	20.32M	18.8M	46.43M	22.43M	53.61M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	62.66M	78.7M	75.95M	137M	332M
Total Assets	10.45B	10.97B	15.46B	18.27B	16.61B
Liabilities
Accounts Payable, Total	483M	648M	2.05B	2.09B	944M
Accrued Expenses, Total	277M	266M	396M	514M	435M
Current Portion of Long-Term Debt	804M	388M	-	620M	393M
Current Portion of Leases	22.94M	33.02M	37.64M	36.34M	37.81M
Current Income Taxes Payable	32.25M	27.67M	135M	255M	95.28M
Other Current Liabilities	183M	511M	121M	46.67M	61.28M
Total Current Liabilities	1.8B	1.87B	2.74B	3.56B	1.97B
Long-Term Debt	2.71B	1.93B	3.14B	3.44B	3B
Long-Term Leases	175M	201M	174M	218M	213M
Unearned Revenue Non Current	-	-	-	78.03M	78.03M
Pension & Other Post Retirement Benefits	389M	273M	192M	177M	148M
Deferred Tax Liability Non Current	395M	353M	481M	558M	358M
Other Non Current Liabilities	513M	537M	537M	577M	642M
Total Liabilities	5.98B	5.17B	7.27B	8.61B	6.41B
Preferred Stock Convertible	-	-	-	-	2.24B
Total Preferred Equity	-	-	-	-	2.24B
Common Stock, Total	1.07M	1.17M	1.17M	1.17M	1.18M
Additional Paid In Capital	1.44B	2.92B	2.94B	2.95B	2.99B
Retained Earnings	3.16B	3.1B	5.6B	6.99B	5.48B
Comprehensive Income and Other	-326M	-392M	-561M	-529M	-742M
Total Common Equity	4.27B	5.63B	7.98B	9.41B	7.73B
Minority Interest	200M	180M	208M	253M	238M
Total Equity	4.47B	5.81B	8.19B	9.67B	10.2B
Total Liabilities And Equity	10.45B	10.97B	15.46B	18.27B	16.61B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	117M	117M	117M	117M	118M
ECS Total Common Shares Outstanding	107M	117M	117M	117M	118M
Book Value / Share	39.95	48.07	68.13	80.2	65.72
Tangible Book Value	2.25B	3.72B	6.08B	7.52B	5.91B
Tangible Book Value Per Share	21.09	31.78	51.87	64.08	50.3
Total Debt	3.71B	2.55B	3.35B	4.31B	3.65B
Net Debt	2.93B	2.08B	1.81B	3.21B	2.4B
Debt Equivalent of Unfunded Proj. Benefit Obligation	348M	236M	167M	159M	123M
Debt Equivalent Oper. Leases	434M	491M	527M	749M	782M
Minority Interest, Total (Incl. Fin. Div)	200M	180M	208M	253M	238M
Equity Method Investments, Total	605M	593M	832M	855M	727M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	29.7M	45.3M	57.9M	60.1M	67.1M
Inventories - Raw Materials, Total	90.3M	110M	164M	188M	138M
Inventories - Work In Process, Total	130M	149M	133M	213M	291M
Inventories - Finished Goods, Total	454M	474M	1.68B	1.62B	913M
Inventories - Others	76.18M	79.86M	99.56M	135M	161M
Land - (BS)	121M	118M	172M	297M	295M
Buildings, Total	355M	384M	493M	699M	933M
Machinery, Total	3.56B	3.62B	4.45B	6.17B	8.19B
Full Time Employees	5.9K	6K	7.4K	9K	8.3K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	2.08M	2.56M	2.53M	2.81M	5.2M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	376M	124M	2.69B	1.57B	-1.18B
Depreciation & Amortization - CF	207M	229M	276M	402M	566M
Amortization of Goodwill and Intangible Assets - (CF)	24.92M	25.33M	24.71M	28.03M	23.04M
Depreciation & Amortization, Total	232M	254M	301M	430M	589M
(Gain) Loss From Sale Of Asset	-7.17M	-296M	8.4M	-71.19M	-
(Gain) Loss on Sale of Investments - (CF)	-4.64M	-3.82M	3.28M	39.86M	63.82M
Asset Writedown & Restructuring Costs	-	-	-	-	1.01B
(Income) Loss On Equity Investments - (CF)	-128M	-95.77M	-772M	-1.85B	-715M
Stock-Based Compensation (CF)	22.84M	20.12M	30.47M	36.54M	32.14M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	394M	230M	1.06B	2.69B	-459M
Change In Accounts Receivable	100M	-49.3M	-786M	-351M	555M
Change In Inventories	51.98M	-127M	-1.61B	-963M	1.56B
Change In Accounts Payable	-31.52M	144M	1.29B	-283M	-862M
Change in Other Net Operating Assets	-207M	144M	-306M	81.65M	105M
Cash from Operations	799M	344M	1.91B	1.33B	702M
Capital Expenditure	-850M	-954M	-1.26B	-2.15B	-1.69B
Sale of Property, Plant, and Equipment	-	-	-	-	29.1M
Cash Acquisitions	-22.57M	-	-162M	-426M	-
Divestitures	-	290M	-	-	-
Investment in Marketable and Equity Securities, Total	9.48M	-2.71M	1.24M	-206M	82.25M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-864M	-667M	-1.42B	-2.78B	-1.57B
Long-Term Debt Issued, Total	590M	60.99M	1.96B	973M	112M
Total Debt Issued	590M	60.99M	1.96B	973M	112M
Long-Term Debt Repaid, Total	-250M	-1.17B	-1.1B	-28.86M	-744M
Total Debt Repaid	-250M	-1.17B	-1.1B	-28.86M	-744M
Issuance of Common Stock	40.44M	1.47B	2.78M	190K	374K
Repurchase of Common Stock	-5.14M	-8.14M	-13.34M	-27.47M	-11.89M
Issuance of Preferred Stock	-	-	-	-	2.24B
Common Dividends Paid	-162M	-178M	-184M	-187M	-189M
Preferred Dividends Paid	-	-	-	-	-123M
Common & Preferred Stock Dividends Paid	-162M	-178M	-184M	-187M	-311M
Other Financing Activities, Total	-36.01M	-123M	-60.68M	-106M	-40.39M
Cash from Financing	177M	50.21M	612M	624M	1.24B
Foreign Exchange Rate Adjustments	21.01M	-35.33M	-37.22M	223M	-67.04M
Net Change in Cash	134M	-307M	1.06B	-609M	302M
Supplemental Items
Cash Interest Paid	66.38M	27.73M	92.1M	102M	151M
Cash Income Tax Paid (Refund)	52.1M	131M	248M	319M	263M
Levered Free Cash Flow	-397M	47.09M	-273M	-1.9B	-1.23B
Unlevered Free Cash Flow	-351M	67.42M	-208M	-1.83B	-1.13B
Change In Net Working Capital	71.11M	-369M	883M	438M	-309M
Net Debt Issued / Repaid	340M	-1.11B	868M	944M	-632M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.14	3.54	12.14	1.73	-2.14
Return on Total Capital	4.13	4.59	16.12	2.29	-2.69
Return On Equity %	10.43	3.89	40.23	18.71	-11.43
Return on Common Equity	9.16	2.5	39.53	18.09	-15.36
Margin Analysis
Gross Profit Margin %	31.86	30.3	42.05	12.45	1.57
SG&A Margin	13.65	10.43	6	6.7	11.07
EBITDA Margin %	23.73	25.88	39.17	9.33	-0.17
EBITA Margin %	17.11	19.01	35.4	5.15	-10.69
EBIT Margin %	16.31	18.25	35.06	4.86	-11.12
Income From Continuing Operations Margin %	14.27	6.01	38.46	17.37	-21.12
Net Income Margin %	12.01	3.72	36.75	16.36	-21.93
Net Avail. For Common Margin %	12.01	3.72	36.75	16.36	-24.47
Normalized Net Income Margin	8.58	9.84	26.1	14.23	1.25
Levered Free Cash Flow Margin	-12.69	1.42	-3.73	-19.75	-22.92
Unlevered Free Cash Flow Margin	-11.23	2.03	-2.84	-19	-20.99
Asset Turnover
Asset Turnover	0.31	0.31	0.55	0.57	0.31
Fixed Assets Turnover	0.59	0.58	1.11	1.15	0.56
Receivables Turnover (Average Receivables)	5.47	6.12	8.38	8	5.5
Inventory Turnover (Average Inventory)	2.81	2.97	2.95	3.97	2.89
Short Term Liquidity
Current Ratio	1.22	1.07	1.89	1.47	1.95
Quick Ratio	0.77	0.61	1.08	0.77	1.15
Operating Cash Flow to Current Liabilities	0.44	0.18	0.7	0.37	0.36
Days Sales Outstanding (Average Receivables)	66.88	59.65	43.58	45.62	66.54
Days Outstanding Inventory (Average Inventory)	130.4	122.99	123.66	91.84	126.67
Average Days Payable Outstanding	91.56	86.66	89.27	88.83	119.72
Cash Conversion Cycle (Average Days)	105.72	95.98	77.97	48.63	73.49
Long Term Solvency
Total Debt/Equity	83.05	43.97	40.92	44.6	35.77
Total Debt / Total Capital	45.37	30.54	29.04	30.85	26.35
LT Debt/Equity	64.54	36.71	40.46	37.81	31.55
Long-Term Debt / Total Capital	35.26	25.5	28.71	26.15	23.24
Total Liabilities / Total Assets	57.24	47.1	47.01	47.1	38.59
EBIT / Interest Expense	6.98	18.68	24.74	4.02	-3.61
EBITDA / Interest Expense	10.9	28.37	28.27	8.54	0.54
(EBITDA - Capex) / Interest Expense	-0.74	-0.95	16.11	-9.98	-9.64
Total Debt / EBITDA	4.66	2.77	1.14	4.35	41.17
Net Debt / EBITDA	3.67	2.25	0.62	3.24	27.03
Total Debt / (EBITDA - Capex)	-69.03	-82.66	2.01	-3.72	-2.28
Net Debt / (EBITDA - Capex)	-54.45	-67.23	1.08	-2.77	-1.5
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-12.83	6.36	119.96	31.38	-44.08
Gross Profit, 1 Yr. Growth %	-20.85	1.17	205.19	-61.11	-92.96
EBITDA, 1 Yr. Growth %	-21.78	16.01	231.44	-68.72	-101.02
EBITA, 1 Yr. Growth %	-29.81	18.17	307.13	-80.89	-216.07
EBIT, 1 Yr. Growth %	-30.61	18.98	319.97	-81.8	-227.97
Earnings From Cont. Operations, 1 Yr. Growth %	-26.1	-55.23	1.31K	-40.66	-167.97
Net Income, 1 Yr. Growth %	-29.53	-67.09	2.07K	-41.5	-174.96
Normalized Net Income, 1 Yr. Growth %	-37.48	22.03	479.33	-28.39	-95.1
Diluted EPS Before Extra, 1 Yr. Growth %	-29.88	-69.89	2.05K	-41.51	-183.83
Accounts Receivable, 1 Yr. Growth %	-13.35	4.91	113.85	1.86	-38.82
Inventory, 1 Yr. Growth %	-2.44	8.36	159.95	4.11	-30.48
Net Property, Plant and Equip., 1 Yr. Growth %	8.87	10.44	16.93	35.84	-1.89
Total Assets, 1 Yr. Growth %	5.98	5.01	40.85	18.21	-9.09
Tangible Book Value, 1 Yr. Growth %	12.75	65.01	63.42	23.75	-21.38
Common Equity, 1 Yr. Growth %	8.54	31.79	41.91	17.91	-17.91
Cash From Operations, 1 Yr. Growth %	11.06	-56.91	454.19	-30.53	-47.03
Capital Expenditures, 1 Yr. Growth %	-0.15	12.13	32.29	70.36	-21.56
Levered Free Cash Flow, 1 Yr. Growth %	986.94	-111.86	-527.93	596.03	-35.11
Unlevered Free Cash Flow, 1 Yr. Growth %	10K	-119.19	-347.39	778.11	-38.2
Dividend Per Share, 1 Yr. Growth %	4.76	1.3	1.28	1.27	0.62
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.71	-3.71	52.95	69.99	-14.29
Gross Profit, 2 Yr. CAGR %	-10.15	-10.48	75.71	8.94	-83.46
EBITDA, 2 Yr. CAGR %	-11.61	-4.44	96.52	1.25	-94.36
EBITA, 2 Yr. CAGR %	-17.03	-8.57	120.01	-12.48	-52.91
EBIT, 2 Yr. CAGR %	-17.48	-8.77	124.23	-13.28	-51.74
Earnings From Cont. Operations, 2 Yr. CAGR %	-22.27	-42.48	151.06	189.05	-36.49
Net Income, 2 Yr. CAGR %	-26.39	-51.84	167.55	256.69	-33.78
Normalized Net Income, 2 Yr. CAGR %	-21.98	-12.27	166.85	94.77	-81.26
Diluted EPS Before Extra, 2 Yr. CAGR %	-25.49	-54.05	154.73	255.02	-29.97
Accounts Receivable, 2 Yr. CAGR %	-6.38	-4.66	49.79	47.59	-21.06
Inventory, 2 Yr. CAGR %	3.49	2.82	66.35	64.51	-14.93
Net Property, Plant and Equip., 2 Yr. CAGR %	34.82	9.66	13.64	26.03	15.44
Total Assets, 2 Yr. CAGR %	17.41	5.49	21.61	29.03	3.66
Tangible Book Value, 2 Yr. CAGR %	17.51	36.4	64.21	42.21	-1.36
Common Equity, 2 Yr. CAGR %	9.11	19.61	36.76	29.35	-1.62
Cash From Operations, 2 Yr. CAGR %	20.94	-30.82	54.53	96.21	-39.34
Capital Expenditures, 2 Yr. CAGR %	10.23	5.81	21.8	50.12	15.59
Levered Free Cash Flow, 2 Yr. CAGR %	170.7	8.23	-17.09	420.9	112.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	304.98	206.81	-23.04	349.72	132.95
Dividend Per Share, 2 Yr. CAGR %	7.2	3.02	1.29	1.27	0.94
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.61	-0.47	26.81	45.4	17.35
Gross Profit, 3 Yr. CAGR %	-4.52	-6.53	34.73	6.29	-56.29
EBITDA, 3 Yr. CAGR %	-4.17	-3.23	44.86	6.51	-78.16
EBITA, 3 Yr. CAGR %	-7.28	-6.65	50.72	-2.57	-3.84
EBIT, 3 Yr. CAGR %	-7.58	-6.78	52.08	-2.91	-1.27
Earnings From Cont. Operations, 3 Yr. CAGR %	64.97	-35.33	67.01	55.23	78.41
Net Income, 3 Yr. CAGR %	89.92	-43.71	71.5	61.18	112.07
Normalized Net Income, 3 Yr. CAGR %	-10.51	-9.43	64.99	72.12	-42.92
Diluted EPS Before Extra, 3 Yr. CAGR %	92.95	-44.91	65.7	55.99	119.43
Accounts Receivable, 3 Yr. CAGR %	-0.22	-2.76	24.8	31.72	10.05
Inventory, 3 Yr. CAGR %	8.17	5.08	39.24	42.29	23.45
Net Property, Plant and Equip., 3 Yr. CAGR %	30.1	26.15	12.03	20.61	15.94
Total Assets, 3 Yr. CAGR %	10.48	13.12	16.16	20.47	14.81
Tangible Book Value, 3 Yr. CAGR %	11.12	31.59	44.87	49.44	16.72
Common Equity, 3 Yr. CAGR %	5.12	16.2	26.62	30.16	11.16
Cash From Operations, 3 Yr. CAGR %	38	-14.26	38.42	18.38	26.81
Capital Expenditures, 3 Yr. CAGR %	38.85	10.86	13.99	36.21	20.91
Levered Free Cash Flow, 3 Yr. CAGR %	37.3	-4.56	89.34	68.51	160.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	45.4	46.56	207.4	73.26	132.07
Dividend Per Share, 3 Yr. CAGR %	6.36	5.2	2.43	1.28	1.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.05	4.45	18.97	23.3	8.42
Gross Profit, 5 Yr. CAGR %	1.7	0.77	21.86	-0.62	-41.77
EBITDA, 5 Yr. CAGR %	0.96	3.43	27.73	-1.15	-60.46
EBITA, 5 Yr. CAGR %	-0.3	2.63	31	-8.63	-5.36
EBIT, 5 Yr. CAGR %	-0.62	2.51	31.75	-9.03	-3.91
Earnings From Cont. Operations, 5 Yr. CAGR %	6.4	-16.02	95.15	17.71	13.44
Net Income, 5 Yr. CAGR %	2.33	-28.1	117.83	17.8	17.21
Normalized Net Income, 5 Yr. CAGR %	-2.59	1.85	38.54	25.43	-30.89
Diluted EPS Before Extra, 5 Yr. CAGR %	5.37	-22.94	115.63	16.08	17.41
Accounts Receivable, 5 Yr. CAGR %	5.93	2.76	17.39	14.9	3.91
Inventory, 5 Yr. CAGR %	11.29	12.54	28.49	25.27	14.34
Net Property, Plant and Equip., 5 Yr. CAGR %	18.79	20.77	23.25	26.1	13.38
Total Assets, 5 Yr. CAGR %	1.72	6.1	14.8	19.23	10.99
Tangible Book Value, 5 Yr. CAGR %	9.83	14.37	29.91	35.74	24.22
Common Equity, 5 Yr. CAGR %	5.57	8.19	16.79	21.29	14.46
Cash From Operations, 5 Yr. CAGR %	17.23	-14.09	44.39	19.4	-0.49
Capital Expenditures, 5 Yr. CAGR %	30.16	37.13	31.76	25.15	14.63
Levered Free Cash Flow, 5 Yr. CAGR %	141.75	-43.78	12.21	103.69	98.29
Unlevered Free Cash Flow, 5 Yr. CAGR %	46.25	-40.15	12.73	143.33	175.12
Dividend Per Share, 5 Yr. CAGR %	5.83	5.04	4.3	3.61	1.84